Chronic myeloid leukemia — before and after imatinib (First part)
The first successful experience effective target therapy has been achieved at imatinib administration in chronic myeloid leukemia (CML) treatment. Disease early considered practically incurable, now successful controlled using little toxic conservative therapy. During tyrosine kinase inhibitors ther...
| Główni autorzy: | , , , |
|---|---|
| Format: | Artykuł |
| Język: | Russian |
| Wydane: |
ABV-press
2022-11-01
|
| Seria: | Онкогематология |
| Hasła przedmiotowe: | |
| Dostęp online: | https://oncohematology.abvpress.ru/ongm/article/view/721 |